Biohit GastroPanel[®] test was studied clinically in patients with autoimmune disease
Press release 25.09.2020 at 15.00 local time (EEST) This study was completed at the Outpatient Department of Internal Medicine (Oulu University Hospital), and the report of the results was recently accepted for publication in an international gastroenterology journal (1). At the moment endoscopic services have been severely curtailed due to the COVID-19 pandemic. This further increases the risk of patients with autoimmune disease developing autoimmune atrophic gastritis (AAG) and even gastric cancer before diagnosis can be made. Biohit´s solution is to use the GastroPanel[®]